Beijing NeuronBC Successfully Concludes CPHI & PMEC 2026, Embarking on a New Compliance-Focused Journey

The three-day CPHI & PMEC China 2026 (China International Exhibition for Pharmaceutical Ingredients; China International Exhibition for Pharmaceutical Machinery, Packaging Equipment & Materials) came to a successful conclusion at Shanghai New International Expo Centre. As an immensely influential annual grand event for the global pharmaceutical sector, the exhibition gathered thousands of domestic and international enterprises specializing in pharmaceutical equipment, raw materials and supporting technologies. Centered on core industry trends including compliance upgrading, technological innovation and intelligent manufacturing, it built an efficient platform for exchange, product display and cooperation within the pharmaceutical industry.

During the exhibition, Beijing NeuronBC made a prominent appearance at Booth A60, Hall W5 with its full range of core pharmaceutical compliance testing equipment. Backed by robust professional product performance, regulatory solutions aligned with domestic and international pharmacopoeias as well as FDA requirements, and mature industry implementation experience, the company garnered extensive attention and recognition from industry counterparts worldwide. The booth maintained a steady stream of visitors and non-stop business discussions throughout the show.

Over the three exhibition days, the venue saw constant heavy foot traffic. Professional visitors flocked to our booth, including representatives from major domestic pharmaceutical manufacturers, biopharmaceutical enterprises, medical device suppliers, pharmaceutical R&D institutions, and clients from numerous overseas countries. They held in-depth exchanges with Beijing NeuronBC’s senior technical engineers and compliance consulting team on key industry pain points such as pharmaceutical production quality inspection, sterile validation, water quality testing and data integrity compliance system construction.

At this exhibition, Beijing NeuronBC showcased its flagship core equipment, including filter integrity testers, total organic carbon (TOC) analyzers, package seal integrity testers, glove integrity testers, bag integrity testers, WRTP integrity testers and freezing-point osmometers. All product lines fully comply with authoritative domestic and international regulatory standards such as Chinese Pharmacopoeia, GMP and 21 CFR Part 11. They are applicable to a wide range of scenarios, including sterile pharmaceutical preparations, biopharmaceutical manufacturing, API production, cleanroom operation & maintenance, and equipment cleaning validation, and can meet diverse demands of pharmaceutical companies covering routine quality inspection, annual validation, export compliance audits and cleanroom renovation and upgrading.

On-site, our technical team elaborated on equipment operation workflows, regulatory compliance key points and customized cleanroom deployment solutions with real-world application cases, providing targeted answers to clients’ questions regarding sterile testing, water quality validation, compliance system establishment and equipment selection & matching. The in-depth professional technical support and practical solutions enabled numerous visitors to gain a direct and thorough understanding of Beijing NeuronBC’s product strengths and brand expertise. Multiple preliminary cooperation intentions and technical collaboration requests were secured on site.

Leveraging the exhibition as a bridge, we unite forces to forge ahead together. The successful conclusion of CPHI & PMEC China 2026 stands as full recognition of Beijing NeuronBC’s products and technologies, as well as a vital opportunity for the brand to deepen its presence in pharmaceutical compliance testing and connect with global pharmaceutical resources.

Moving forward, Beijing NeuronBC will continue to cater to the compliance development demands of the pharmaceutical industry, adhering to the development philosophy of independent innovation, compliance as the foundation and quality as the priority. We will continuously upgrade and optimize the performance of testing equipment and refine full-set compliance solutions, focusing on core segments including pharmaceutical sterile testing, water quality analysis, protective leak detection and data compliance validation. Meanwhile, we will keep track of updated industry regulations and market trends. With more professional products and premium technical services, we will assist domestic and international pharmaceutical enterprises in cutting costs, boosting efficiency, mitigating compliance risks and strengthening production quality control systems. We stand ready to join hands with all industry partners to jointly create a new blueprint for high-quality development of the pharmaceutical industry!